COVID-19: a conundrum to decipher.
CONCLUSIONS: SARS-Cov-2 has emerged as a worldwide threat, currently affecting 170 countries and territories across the globe. There is still much to be understood regarding SARS-CoV-2 about its virology, epidemiology and clinical management strategies; this knowledge will be essential to both manage the current pandemic and to conceive comprehensive measures to prevent such outbreaks in the future. PMID: 32495923 [PubMed - in process]
Publication date: Available online 10 July 2020Source: Clinica Chimica ActaAuthor(s): Aditya K. Panda, Archana Padhi, B. Anjan Kumar Prusty
Publication date: Available online 10 July 2020Source: Clinica Chimica ActaAuthor(s): Xingzhong Hu, Dong Chen, Lianpeng Wu, Guiqing He, Wei Ye
Publication date: Available online 9 July 2020Source: Obesity Research &Clinical PracticeAuthor(s): Abdulzahra Hussain, Kamal Mahawar, Zefeng Xia, Wah Yang, Shamsi EL-Hasani
In this study, we investigated the antitumor activity of H2Mab-19 in an LN229 glioblastoma xenograft model. H2Mab-19 showed high binding affinity (KD: 1.1 × 10-8 M) against LN229 cells. Furthermore, H2Mab-19 significantly reduced tumor development in an LN229 xenograft. These results suggest that treatment with H2Mab-19 may be a useful therapy for patients with HER2-expressing glioblastomas. PMID: 32644843 [PubMed - as supplied by publisher]
Publication date: Available online 10 July 2020Source: The Annals of Thoracic SurgeryAuthor(s): Andrea Marudi, Giacomo Branchetti, Elisabetta Bertellini
Publication date: Available online 9 July 2020Source: The Annals of Thoracic SurgeryAuthor(s): Gianluca Folesani, Luca Botta, Davide Pacini
Publication date: Available online 10 July 2020Source: Antiviral ResearchAuthor(s): So Young Kim, Weihua Jin, Amika Sood, David W. Montgomery, Oliver C. Grant, Mark M. Fuster, Li Fu, Jonathan S. Dordick, Robert J. Woods, Fuming Zhang, Robert J. Linhardt
This report provides basic genetic data on genotype D11 for further study of me asles evolution and the support for measles elimination.
The objective of this study was to develop and validate a real-time quantitative PCR (RT-qPCR) protocol for the diagnosis of COCV directly from epithelial samples. The method developed had 97% accuracy at 3950 pfu and a repeatability error of 1.29%. RT-qPCR was able to distinguish COCV from other viruses that cause vesicular diseases, an important factor because seroneutralization may produce cross-reactivity between COCV and vesicular stomatitis Alagoas virus (VSAV). No epithelial sample originating from vesicular disease outbreaks between 2014 and 2018 in Brazil was positive for COCV.
Publication date: Available online 10 July 2020Source: Journal of Microbiology, Immunology and InfectionAuthor(s): Jae-Hoon Ko, Eun-Jeong Joo, Sung-Han Kim, Yae-Jean Kim, Kyungmin Huh, Sun Young Cho, Cheol-In Kang, Doo Ryeon Chung, Eun-Suk Kang, Kyong Ran Peck
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Coronavirus | Cough | COVID-19 | Diabetes | Diabetes Mellitus | Drugs & Pharmacology | Emergency Medicine | Endocrinology | Epidemiology | Headache | Heart | Hypertension | International Medicine & Public Health | MERS | Middle East Health | Migraine | Outbreaks | Pandemics | Pneumonia | Respiratory Medicine | SARS | Science | Sore Throat | Virology | WHO